Myofascial Line Training Effects on Mobility and Endurance in Adolescent Football Players (NCT07699822) | Clinical Trial Compass
CompletedNot Applicable
Myofascial Line Training Effects on Mobility and Endurance in Adolescent Football Players
Turkey (Türkiye)38 participantsStarted 2025-05-05
Plain-language summary
This study compared the effects of two myofascial chain training programs - the Superficial Posterior Line (PL) and the Spiral Line (SL) - on joint mobility and myofascial isometric endurance in adolescent male football players. Thirty-eight licensed male players (ages 15-16) were enrolled in a randomized crossover trial consisting of two 6-week training phases (12 weeks total), with follow-up measurements at week 16. Each program was delivered twice weekly in 30-minute sessions alongside regular club training. Joint mobility was assessed using goniometry (shoulder flexion, hip flexion, hip extension, popliteal angle), and myofascial isometric endurance was evaluated using the Bunkie Test across five lines (APL, PPL, PSL, LSL, MSL).
Who can participate
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male, aged 15-16 years (U15-U16 category)
* Holding an active football player license and currently competing with a club team
* Regularly participating in routine club training sessions
* Free from any injury or musculoskeletal condition that could affect -performance testing at the time of enrollment
* Parental/legal guardian consent and participant assent obtained
Exclusion Criteria:
* Presence of any musculoskeletal injury, recent surgery, or medical condition affecting lower-limb function within the past 6 months
* Inability to attend the required training sessions or assessment time points
* Unwillingness or inability of parents/legal guardians to provide informed consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.